Infinium Pharmachem Limited (NSE:INFINIUM)

India · Delayed Price · Currency is INR

276.00

+6.05 (2.24%)

Nov 11, 2026, 12:28 PM IST

Infinium Pharmachem Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	2,356	1,896	1,557	1,357	1,142	991.19
Revenue Growth	24.26%	21.79%	14.78%	18.77%	15.24%	81.01%
Gross Profit	470.57	407.13	378.89	316.45	332.05	222.01
Operating Income	224.71	185.04	132.7	158.89	147.16	94.13
Net Income	154.75	121.5	81.45	113.02	94.9	61.06
Earnings Per Share	9.94	7.80	5.60	10.61	9.33	6.01
EPS Growth	27.46%	39.23%	-47.21%	13.64%	55.41%	124.55%

Revenue by Segment

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Intermediate Chemicals	1,859	1,524	1,339	1,142	991.19
Biocall	31.23	33.25	18.06	-	-
Total	1,890	1,557	1,357	1,142	991.19

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	308.81	297.81	348.4	119.11	59.79	54.51
Total Debt	-	154.54	418.49	34.38	292.4	225.21
Net Cash (Debt)	308.81	143.27	-70.09	84.73	-232.6	-170.69
Net Cash Growth	115.55%	-	-	-	-	-
Net Cash Per Share	19.83	9.19	-4.82	7.95	-22.88	-16.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	388.47	337.34	-291.43	49.18	85.9	117.96
Capital Expenditures	-102.61	-96.85	-52.53	-35.12	-74.66	-47.27
Free Cash Flow	285.86	240.49	-343.96	14.06	11.23	70.69
Free Cash Flow Growth	18.87%	-	-	25.14%	-84.11%	219.67%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	19.97%	21.47%	24.33%	23.33%	29.07%	22.40%
Operating Margin	9.54%	9.76%	8.52%	11.71%	12.88%	9.50%
Pretax Margin	9.56%	9.41%	7.43%	11.21%	11.34%	8.71%
Profit Margin	6.57%	6.41%	5.23%	8.33%	8.31%	6.16%
FCF Margin	12.13%	12.68%	-22.09%	1.04%	0.98%	7.13%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 11, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	27.77	24.73	41.33	28.20	-	-
P/FCF Ratio	15.05	12.49	-	226.68	-	-
PS Ratio	1.83	1.58	2.16	2.35	-	-